DN200434 Inhibits Vascular Smooth Muscle Cell Proliferation and Prevents Neointima Formation in Mice after Carotid Artery Ligation

Pharmacology, Toxicology and Pharmaceutical Science

• Mouse 100%
• Neointima 100%
• Platelet Derived Growth Factor 66%
• Peripheral Occlusive Artery Disease 66%
• C57BL 6 Mouse 33%
• Atherosclerosis 33%
• Flow Cytometry 33%
• Sprague Dawley Rat 33%
• Estrogen Receptor 33%
• Mammalian Target of Rapamycin Complex 1 33%
• Inverse Agonist 33%
• Seahorse 33%
• Hyperplasia 33%

Medicine and Dentistry

• Cell Proliferation 100%
• Neointima 100%
• Vascular Smooth Muscle Cell 100%
• Oxidative Phosphorylation 66%
• Platelet Derived Growth Factor 33%
• Arteriosclerosis Obliterans 33%
• Atherosclerosis 16%
• Precursor 16%
• Flow Cytometry 16%
• Inverse Agonist 16%
• Mitochondrial Respiration 16%
• Cell Cycle 16%
• Cell Cycle Progression 16%
• Thoracic Aorta 16%
• Estrogen Receptor 16%
• Left Common Carotid Artery 16%

Biochemistry, Genetics and Molecular Biology

• Mouse 100%
• Cell Proliferation 100%
• Oxidative Phosphorylation 100%
• Platelet-Derived Growth Factor 50%
• Cell Cycle Progression 25%
• C57BL 6 Mouse 25%
• Flow Cytometry 25%
• Precursor 25%
• Mitochondrial Respiration 25%
• Sprague Dawley Rat 25%
• Cell Cycle 25%
• Estrogen-Related Receptor Gamma 25%
• Inverse Agonist 25%
• Mammalian Target of Rapamycin Complex 1 25%